Topical benzydamine cream and the relief of pressure pain.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 15453623.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To determine whether topical benzydamine hydrochloride 3% cream is more effective than placebo in reducing pain related to pressure areas in palliative care patients. Randomized double-blind, placebo-controlled trial. Three specialist palliative care units in the north of England, with local ethical committee approval for all sites. Hospice in-patients with pain related to pressure areas. A single application of either benzydamine hydrochloride 3% cream or placebo cream to the painful pressure area. Pain assessed using 100 mm VAS, an 11-point numerical pain score and a five-point pain relief score. There was no statistically significant difference between topical benzydamine hydrochloride 3% cream and placebo cream in reducing pain related to pressure areas in palliative care patients. This study does not demonstrate a statistically significant difference between the two treatments. However the study does provide reliable information with respect to the use of different pain measurement tools in late-stage palliative patients. It also provides information regarding the baseline characteristics of this group of patients which may be useful in the planning of any future similar studies.
Medical subject headings
- Anti-Inflammatory Agents, Non-Steroidal
- Benzydamine
- Pain
- Palliative Care
- Pressure Ulcer